Kronos Bio (NASDAQ:KRON) reported quarterly losses of $(0.59) per share. This is a 11.32 percent decrease over losses of $(0.53) per share from the same period last year.
Ra Medical Systems Regains Compliance With NYSE American Continued Listing Standards
Ra Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company") announces that it has received notification from the NYSE American LLC ("NYSE American") that the Company has regained
